$ONG is getting attention from both the hard fork and increased trading activity. The key question is whether the improved Ethereum compatibility can translate into higher network usage after the upgrade.

Meanwhile, $MRNA just pulled off a massive 177% move in a single day.

The surge followed Moderna’s personalized mRNA cancer treatment, combined with Merck’s Keytruda, meeting key Phase 3 endpoints in melanoma patients.

A major step for personalized cancer treatment, but regulatory approval is still required before wider access.

The move also highlights how quickly biotech stocks can react to major clinical data. $MRNA is definitely one to keep on the radar.

#Moderna #MRNA #BingX